Related Experiment Video
Updated: Jul 22, 2025

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with
Nipun Verma1, P Venkata Divakar Reddy2, Shashi Vig3
1Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Background & Aims:
The reported burden of multidrug-resistant organism (MDRO) infections is highest in patients with cirrhosis from India. We evaluated whether colonisation at multiple barriers predisposes to such infections and poor outcomes in patients with cirrhosis.
Methods:
We prospectively performed swab cultures, antimicrobial susceptibility testing (AST), and genotype testing for MDROs from various sites (rectum, nose, composite-skin, and central-line) in patients with cirrhosis (2020-2021) on admission and follow-up at a tertiary institute. We analysed clinical data, risk factors for MDROs, and patient outcomes.
Results:
Of 125 patients aged 49 years, 85.6% males, 60.8% with acute-on-chronic liver failure, 99 (79.2%) were identified as 'colonisers'. MDRO-colonisation at rectum, nose, skin, or central line was observed in 72.7% (88/121), 30.0% (36/120), 14.9% (18/121), and 3.3% (4/121) patients, respectively. Patients were colonised with the following types of bacteria: extended-spectrum beta-lactamase (71/125), carbapenem-resistant Enterobacterales (67/125), MDR-Enterococcus (48/125), MDR-Acinetobacter (21/125), or methicillin-resistant Staphylococcus aureus (4/125). Multiple precipitants of acute-decompensation (odds ratio [OR]: 3.4, p = 0.042), norfloxacin prophylaxis (OR: 3.9, p = 0.008), and MDRO infection at admission (OR: 8.9, p = 0.041) were the independent predictors of colonisation. Colonisation increased the risk of infection by MDROs at admission (OR: 8.5, p = 0.017) and follow up (OR: 7.5, p <0.001). Although any-site colonisers were at greater risk of cerebral failure and poorer Child-Pugh scores, the nasal and skin colonisers were at higher risk of cerebral and circulatory failures than non-colonisers (p <0.05).Patients with more than one site colonisation (prevalence: 30%) developed multi-organ failure (p <0.05), MDRO infection (OR: 7.9, p <0.001), and poorer 30-day survival (hazard ratio: 2.0, p = 0.005).
Conclusions:
A strikingly high burden of MDRO colonisation among patients with cirrhosis in India necessitates urgent control measures. Multiple-site colonisation increases the risk of MDR-infections, multi-organ failure, and mortality in patients with cirrhosis.
Impact And Implications:
Infections by bacteria resistant to multiple antibiotics are an emerging cause of death in cirrhosis. We showed that ∼70-80% of critically ill hospitalised patients with cirrhosis carry such bacteria with the highest rate in the rectum, nose, skin, and central line port. Carbapenem-resistant and vancomycin-resistant bacteria were amongst the most common colonising bacteria. The presence of these bacteria at multiple sites increased the risk of multidrug-resistant infections, multiple organ failures, and death in patients with cirrhosis.
Insights
Multidrug-resistant organism (MDRO) colonization is common in Indian patients with cirrhosis. Multiple colonization sites significantly increase the risk of MDRO infections, organ failure, and mortality.
Area of Science:
- Infectious Diseases
- Hepatology
- Microbiology
Background:
- Multidrug-resistant organism (MDRO) infections pose a significant threat, particularly in patients with cirrhosis.
- India reports a high burden of MDRO infections among cirrhosis patients, necessitating investigation into colonization patterns.
Purpose of the Study:
- To evaluate if colonization at multiple body sites predisposes cirrhosis patients to MDRO infections and poor outcomes.
- To identify risk factors associated with MDRO colonization in patients with cirrhosis.
Main Methods:
- Prospective study involving swab cultures, antimicrobial susceptibility testing (AST), and genotype testing for MDROs from various sites (rectum, nose, skin, central line).
- Analysis of clinical data, risk factors for MDRO colonization, and patient outcomes (infections, organ failure, survival) in cirrhosis patients.
- Conducted between 2020-2021 at a tertiary institute, including admission and follow-up assessments.
Main Results:
- 79.2% of 125 cirrhosis patients were identified as 'colonizers' for MDROs.
- High colonization rates observed at the rectum (72.7%), nose (30.0%), and skin (14.9%). Common MDROs included extended-spectrum beta-lactamase producers and carbapenem-resistant Enterobacterales.
- Multiple-site colonization (30% of patients) was independently associated with increased risk of MDRO infection (OR: 7.9), multi-organ failure, and poorer 30-day survival (HR: 2.0).
Conclusions:
- A high prevalence of MDRO colonization exists in Indian patients with cirrhosis, demanding urgent control strategies.
- Colonization at multiple body sites significantly elevates the risk of developing MDRO infections, multi-organ failure, and mortality in this vulnerable population.
More Related Videos
Related Concept Videos
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Hepatic Drug Clearance: Role of Transporters
Hepatic Drug Excretion: Influencing Factors

